1,2-DITHIOLANE AND DITHIOL COMPOUNDS USEFUL IN TREATING MUTANT EGFR-MEDIATED DISEASES AND CONDITIONS
申请人:Sabila Biosciences LLC
公开号:US20180208584A1
公开(公告)日:2018-07-26
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.
该发明的组合物包括1,2-二硫杂环烷、二硫醇和相关化合物,可用作治疗剂,用于治疗和预防与EGFR活性异常相关的疾病和病况。